MXCT

1.3757.42%
PJ

Patrick J. Balthrop

Independent Non-Executive Director

Mr. Patrick J. Balthrop, Sr. also known as Pat serves as an Executive Advisor at Water Street Healthcare Partners. On behalf of Water Street, he also serves as Chairman of Discovery Life Sciences. He is the Founding Principal of Apalachee Ventures, LLC. Mr. Balthrop also serves as Director at Ascential Technologies, Independent Non-Executive Director at MaxCyte, Inc. since November 2022, Chairman of the Supervisory Board at Agendia N.V. since 2021, Advisor at Warburg Pincus, Lead Independent Director at Pattern Bioscience, Inc., and Director at Folio Conversant. Previously, he served as a Director of ChromaCode, Inc. since August 2021. At Oxford Immunotec Global PLC, he served as Chairman from June 2019 to March 2021 and as a Non-Executive Director from January 2016 to March 2021. He also served as a Director of Personalis, Inc. from July 2015 to March 2021. He was Chairman of Agendia N.V. since April 2017 and Chairman of Agendia, Inc. since April 2017. He served as a Director of Concert Genetics, Inc. since March 2014. From May 2004 to October 2014, he served as Chief Executive Officer, President, and a Director of Luminex Corporation. Under his leadership, the company grew from $30 million in revenue to more than $200 million, significantly increased its profits, and was honored by Forbes and Fortune as one of the fastest growing companies. He served as President of Fisher Healthcare from 2002 to 2004. From 1981 to 2002, he served in several leadership positions with Abbott Laboratories, including as Head of worldwide commercial diagnostics operations and as Head of Abbott Vascular. Mr. Balthrop holds an MBA from the Kellogg Graduate School of Management of Northwestern University and a B.S. in Biology from Spring Hill College.

Positions